A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Study sponsor: Nektar Therapeutics · NKTR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-08-09Actual
Enrollment · participants81Actual
Source updated2023-09-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.